BioIntraface Inc. (BI) is a leading brand that specializes in designing bioactive and antimicrobial medical coatings. With strong connections to academic, clinical, and industry partners such as Brown University, Rhode Island Hospital, and the medical device industry, BI is able to develop applications that are not only technically feasible but also clinically relevant and commercially viable.

The core focus of BI's technology lies in anti-bacterial and bioactive coatings for fracture fixation, although there are ongoing developments for other uses as well. These surface treatment technologies are non-cytotoxic and exhibit resistance against bacterial growth and biofilm formation, without promoting bacterial drug resistance. By offering a scientifically-proven reduction in infection rates compared to traditional non-coated devices, BI's coatings provide a compelling choice for patients, clinicians, insurance companies, and hospitals.

Furthermore, BI's management, with their extensive experience in the medical device industry and coating technology, is well-equipped to navigate regulatory hurdles and expand into new product lines of antimicrobial and bioactive medical devices. Discover more about BioIntraface's groundbreaking technology by visiting their website